Ocular toxicity of fluorouracil after vitrectomy.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  American journal of ophthalmology-glaucoma

• Publication date

  1983-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9394(83)90453-1PMID 6869479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.

  1983cited by this paper
• The clearance of intravitreal triamcinolone acetonide.

  1982cited by this paper
• Epiretinal membrane formation after vitrectomy.

  1982cited by this paper
• The Incorporation of 5-Fluorouracil Into RNA and its Molecular Consequences

  1969cited by this paper
• Ribosome synthesis in Escherichia coli treated with 5-fluorouracil.

  1966cited by this paper
• Ribosome production during recovery from puromycin treatment: influence of 5-fluorouracil.

  1966cited by this paper
• BIOCHEMICAL MECHANISMS OF ACTION OF FLUORINATED PYRIMIDINES.

  1963cited by this paper

• Retinal toxicities of Systemic Anticancer Drugs.

  2021cites this paper
• Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis

  2021cites this paper
• Comparative cytotoxic and antiproliferative profile of methotrexate and fluorouracil on different ocular cells

  2020cites this paper
• Adjunctive Pharmacological Therapies in the Management of Proliferative Vitreoretinopathy

  2018cites this paper
• A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation

  2017cites this paper
• IV.F. Pharmacotherapy of Proliferative Vitreoretinopathy

  2014cites this paper
• The impact of octreotide in experimental proliferative vitreoretinopathy

  2013cites this paper
• Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo

  2012cites this paper
• THE IMPACT OF TACROLIMUS ON GROWTH FACTORS IN EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY

  2012cites this paper
• OPIOID CODRUGS FOR PAIN MANAGEMENT

  2011cites this paper
• Improving the Use of Drug Combinations Through the Codrug Approach

  2011cites this paper
• Chemotherapy-related visual system toxicity.

  2010cites this paper
• Intravitreal crystalline drug delivery for intraocular proliferation diseases.

  2010cites this paper
• Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy‐induced ‘chemo‐fog’

  2010cites this paper
• Intravitreal concentrations of some drugs administered with microdialysis.

  2009cites this paper
• The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant.

  2009cites this paper
• INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS

  2009cites this paper
• Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.

  2007cites this paper
• The Role of Combined Adjunctive 5-Fluorouracil and Low Molecular Weight Heparin in Proliferative Vitreoretinopathy Prevention

  2007cites this paper
• Toxicity of Subretinal Ribozyme to the Proliferating Cell Nuclear Antigen and 5-Fluorouracil in Rat Eyes

  2006cites this paper
• Approcci farmacologici per migliorare il risultato chirurgico dopo riaccollamento retinico

  2006cites this paper
• Chapter 114 – Vitreoretinal Interface

  2006cites this paper
• Update on ocular complications of systemic cancer chemotherapy.

  2006cites this paper
• Chapter 132 – The Mechanism of Action of Drugs for the Treatment of Vitreoretinal Scarring

  2006cites this paper
• Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by alkylphosphocholines.

  2006cites this paper
• Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases

  2005cites this paper
• Chemotherapeutische Nebenwirkungen im Augenbereich

  2005cites this paper
• Évaluation clinique de 5FU-héparine dans la prévention de la prolifération vitréorétinienne

  2005cites this paper
• [Prevention of proliferative vitreoretinopathy using 5-FU heparin: clinical tolerance and efficacy].

  2005cites this paper
• Pharmacological Approaches to Improve Surgical Outcomes After Retinal Reattachment Surgery

  2005cites this paper
• Intravitreal liposome-encapsulated drugs: A preliminary human report

  2004cites this paper
• Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU

  2004cites this paper
• Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR

  2004cites this paper
• Adjuvants pharmacologiques du traitement chirurgical de la prolifération vitréorétinienne

  2004cites this paper
• Effects of subconjunctival 5-fluorouracil injections on the corneal endothelium and ciliary epithelium

  2004cites this paper
• [Pharmacological adjuvants for surgical treatment of proliferative vitreoretinopathy].

  2004cites this paper
• Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil.

  2003cites this paper
• Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits

  2002cites this paper
• Effect of Tranilast on Proliferation, Collagen Gel Contraction, and Transforming Growth Factor Beta Secretion of Retinal Pigment Epithelial Cells and Fibroblasts

  2002cites this paper
• Simple retinal detachments: identifying the at-risk case

  2002cites this paper
• Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells.

  2002cites this paper
• Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.

  2001cites this paper
• Mechanism of growth inhibitory effect of Mitomycin-C on cultured human retinal pigment epithelial cells: Apoptosis and cell cycle arrest

  2001cites this paper
• Biodegradable scleral plugs for vitreoretinal drug delivery.

  2001cites this paper
• PHARMACOKINETICS OF THE FLUOCINOLONE/5‐FLUOROURACIL CODRUG IN THE GAS‐FILLED EYE

  2000cites this paper
• Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy

  1998cites this paper
• cis-Hydroxyproline inhibits proliferation, collagen synthesis, attachment, and migration of cultured bovine retinal pigment epithelial cells.

  1997cites this paper
• 5-Fluorouracil reduces scarring after strabismus surgery.

  1997cites this paper
• The inhibition of vitamin K3 on rabbit fibroblast proliferation in vitro.

  1996cites this paper
• Sustained-release subconjunctival 5-fluorouracil.

  1996cites this paper
• Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

  1996cites this paper
• In vitro evaluation of polymeric matrix and porous biodegradable reservoir devices for slow-release drug delivery.

  1996cites this paper
• Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

  1995cites this paper
• Delivery systems for intraocular routes

  1995cites this paper
• Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines

  1994cites this paper
• Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.

  1993cites this paper
• The effects of 5-fluorouracil and mitomycin C on the corneal endothelium.

  1992cites this paper
• [Drug and physiotherapeutic correction of post-traumatic vitreoretinal proliferation (review of the literature)].

  1992cites this paper
• The effects of the fluorinated pyrimidines FUR, FUdR, FUMP, and FdUMP on human Tenon's fibroblasts.

  1991cites this paper
• Corneal penetration of 5-fluorouracil and its improvement by prodrug derivatization in the albino rabbit: implication in glaucoma filtration surgery.

  1991cites this paper
• Antiproliferative Medikamente in der Glaskörperchirurgie — ein Überblick

  1991cites this paper
• Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry.

  1991cites this paper
• Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes.

  1991cites this paper
• Effects of fluorouracil and fluorouridine on protein synthesis in rabbit retina.

  1990cites this paper
• Long-term Inhibition of Cellular Proliferation by Immunotoxins

  1990cites this paper
• Long-term inhibition of cellular proliferation by immunotoxins.

  1990cites this paper
• Selection of therapeutic agents for intraocular proliferative disease 3. Effects of fluoropyrimidines on cell-mediated contraction of human fibroblasts.

  1989cites this paper
• Intravitreal drug therapy.

  1989cites this paper
• The use of a liposome-encapsulated 5-fluoroorotate for glaucoma surgery: I. Animal studies.

  1989cites this paper
• Five Fluorouracil Buckles and Retinal Pigment Epithelium (RPE) Proliferation In Situ

  1988cites this paper
• Quantification of cellular proliferation in experimental proliferative vitreoretinopathy.

  1988cites this paper
• In vitro inhibition of lens epithelial cell proliferation and migration.

  1988cites this paper
• The effect of fluorouracil on the corneal endothelium.

  1988cites this paper
• Concentration change of fluorouracil in the external segment of the eye after subconjunctival injection.

  1988cites this paper
• Polyvinyl Alcohol Membrane Permeability Characteristics of 5-Fluorouracil

  1988cites this paper
• Antiproliferative and anticontractile effects of liposome encapsulated fluoroorotate.

  1987cites this paper
• Glaucoma filtering surgery with 5-fluorouracil.

  1987cites this paper
• Clearance and localization of intravitreal liposomes in the aphakic vitrectomized eye.

  1987cites this paper
• In vivo effects of 5-FU on ocular surface epithelium following corneal wounding.

  1987cites this paper
• Multivesicular liposomes. Sustained release of the antimetabolite cytarabine in the eye.

  1987cites this paper
• Research update: report from a workshop on cell biology of retinal detachment.

  1986cites this paper
• Topical fluorouracil. II. Postoperative administration in an animal model of glaucoma filtering surgery.

  1986cites this paper
• Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid.

  1986cites this paper
• Proliferative Vitreoretinopathie - Pathogenese und Möglichkeiten der Behandlung mit Zytostatika

  1986cites this paper
• Intraocular injection of depomedrone.

  1986cites this paper
• Experimental posterior perforating ocular injury: a controlled study of the gross effects of localised gamma irradiation.

  1986cites this paper
• Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectin.

  1986cites this paper
• Topical application of 5-Fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid

  1986cites this paper
• Fluoropyrimidine treatment of ocular cicatricial disease.

  1986cites this paper
• [Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].

  1986cites this paper
• Aqueous concentrations of fluorouracil after intravitreal injection. Normal, vitrectomized, and silicone-filled eyes.

  1986cites this paper
• 5-Fluorouracil toxicity to the ocular surface epithelium.

  1985cites this paper
• Proliferative vitreoretinopathy and chemotherapeutic agents.

  1985cites this paper
• Effects of selected repeated intravitreal chemotherapeutic agents

  1985cites this paper
• MODELS FOR ASSESSING SCAR TISSUE INHIBITORS

  1985cites this paper
• Evaluation of intravitreal 5-fluorouracil, vincristine, VP 16, doxorubicin, and thiotepa in primate eyes.

  1984cites this paper
• 5-Fluorouracil and glaucoma filtering surgery. III. Intermediate follow-up of a pilot study.

  1984cites this paper
• Toxic effect of fluorouracil on the rabbit retina.

  1984cites this paper
• 5-fluorouracil and glaucoma filtering surgery. II. A pilot study.

  1984cites this paper
• Evaluation of toxicity of intravitreal antineoplastic drugs.

  1984cites this paper